Detalhe da pesquisa
1.
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
N Engl J Med
; 382(7): 597-609, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31825569
2.
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neck.
Invest New Drugs
; 32(6): 1197-203, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916771
3.
Evaluating dosimetric accuracy of flattening filter free compensator-based IMRT: measurements with diode arrays.
Med Phys
; 39(1): 342-52, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22225304
4.
Evaluation of Safety and Clinically Relevant Drug-Drug Interactions with Tucatinib in Healthy Volunteers.
Clin Pharmacokinet
; 61(10): 1417-1426, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931943
5.
The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment.
Clin Pharmacokinet
; 61(12): 1761-1770, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36471222
6.
Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
J Clin Pharmacol
; 61(4): 461-471, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989831
7.
Validation of Pinnacle treatment planning system for use with Novalis delivery unit.
J Appl Clin Med Phys
; 11(3): 3240, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20717094
8.
Simulation of intrafraction motion and overall geometrical accuracy of a frameless intracranial radiosurgery process.
J Appl Clin Med Phys
; 9(4): 68-86, 2008 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19020489
9.
A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid Tumors.
Clin Cancer Res
; 24(1): 22-32, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051322
10.
Knowledge, attitudes and practices of Australian medical students towards influenza vaccination.
Vaccine
; 34(50): 6193-6199, 2016 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836439
11.
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma.
Clin Colorectal Cancer
; 15(4): 337-344.e2, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118441
12.
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer.
Oral Oncol
; 51(4): 383-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25593016
13.
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer.
J Thorac Oncol
; 9(7): 1031-1035, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24926548
14.
Toughening in graphene ceramic composites.
ACS Nano
; 5(4): 3182-90, 2011 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21443241
15.
Transplanted human bone marrow contributes to vascular endothelium.
Proc Natl Acad Sci U S A
; 101(48): 16891-6, 2004 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15548607